Study identifier:5077IL/0107
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Multicentre, Open Label, Non-Comparative Trial Examining The Clinical Benefit Derived By Patients Receiving Quetiapine.
schizophrenia
Phase 4
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
-
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|